Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1980 Feb;77(2):1159-63.
doi: 10.1073/pnas.77.2.1159.

Free radicals and inflammation: superoxide-dependent activation of a neutrophil chemotactic factor in plasma

Free radicals and inflammation: superoxide-dependent activation of a neutrophil chemotactic factor in plasma

W F Petrone et al. Proc Natl Acad Sci U S A. 1980 Feb.

Abstract

The intravenous administration of superoxide dismutase (superoxide:superoxide oxidoreductase, EC 1.15.1.1) to animals with induced inflammation suppresses the inflammatory response and inhibits leukocyte infiltration into the challenged site, suggesting that neutrophil-generated superoxide reacts with an extracellular precursor to generate a substance chemotactic for neutrophils. Plasma exposed to superoxide in vitro becomes potently chemotactic. The appearance of chemotactic activity is inhibited by superoxide dismutase but not by catalase. The chemotactic factor does not stimulate superoxide production or degranulation in neurtrophils. Intradermal injection of superoxide-treated plasma or of a superoxide-generating system causes heavy infiltration of neutrophils to the injection site but does not cause overt signs of inflammation. The chemotactic factor consists of a chloroform-extractable component bound to serum albumin. The superoxide-dependent chemotactic factor appears to play a major role in communication in neutrophil-mediated inflammatory events. Prevention of production of this factor appears to be the major anti-inflammatory action of superoxide dismutase.

PubMed Disclaimer

References

    1. Arch Biochem Biophys. 1976 Oct;176(2):577-81 - PubMed
    1. J Clin Invest. 1977 Jan;59(1):179-83 - PubMed
    1. J Immunol. 1978 Feb;120(2):526-31 - PubMed
    1. Ann Intern Med. 1978 Jul;89(1):122-7 - PubMed
    1. Biochem Biophys Res Commun. 1978 Aug 14;83(3):927-32 - PubMed

Publication types

LinkOut - more resources